| |
|
|
|
Adial Pharmaceuticals Inc.  
|
|
1.32 0.02 (0.02%) |
09-18 16:00 |
|
Open: |
1.3 |
Pre close: |
1.3 |
Target:
|
1.72 
|
|
High: |
1.39 |
Low: |
1.3 |
Resistance:
|
1.47
1.64
|
|
Volume: |
169,397 |
Market Cap: |
18M |
Support:
|
1.20
1.00
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.32
 |
MACD |
MACD(12,26):
|
-0.06 |
|
MA(20): |
1.35 |
Signal(12,26,9): |
-0.06 |
|
MA(100): |
1.48 |
Stochastic Oscillator |
%K(14,3):
|
30.48 |
|
MA(250): |
1.58 |
%D(3): |
32.06 |
|
Average Volume(K) |
3-Month: |
82345
|
52-Week |
High:
|
3.17 |
|
10-Days: |
19506 |
Low: |
1.00 |
|
RSI |
RSI(14):
|
44.23 |
Change(%): |
-11.4 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.736 |
Return on Equity (ttm) |
-83.4 |
Shares Out. (M) |
13.56 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-49.3 |
Shares Float (M) |
11.09 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
31.74 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
5.89 |
|
Forward EPS |
-0.870 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
515 |
|
Book Value (p.s.) |
0.650 |
EBITDA (p.s.) |
-0.587 |
P/E |
-1.79 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.03 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-6.29 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-3.51 |
P/CF |
-2.85 |
|
|
|
|
|
|
